Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Middle aortic coarctation is a rare vascular anomaly characterized by the segmental narrowing of the abdominal and/or distal descending thoracic aorta with varying involvement of the visceral and renal arteries that commonly presents in children and young adults with early onset and refractory hypertension, abdominal angina, lower-limb claudication and that can lead to life-threatening complications associated with severe hypertension (i.e. myocardial infarction, heart failure, aortic rupture, renal insufficiency and intracranial hemorrhage). It may be due to various congenital or acquired causes, but it is most often secondary to an acquired inflammatory disease (i.e. Takayasu arteritis or giant cell arteritis).
Biomarker and diagnostic research for atypical coarctation of aorta has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for atypical coarctation of aorta.
64 publications have been identified in PubMed for atypical coarctation of aorta. Research spans Case Report / Case Series (61%), Review / Meta-Analysis (13%), and Epidemiology / Natural History (8%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 39 | 61% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:51 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries
8 |
13% |
Disease patterns and progression | 5 | 8% |
Laboratory research | 4 | 6% |
Testing and diagnosis research | 3 | 5% |
Clinical study results | 3 | 5% |
Other research | 2 | 3% |
Fayisa S (2026). [PMID: 41675836](https://pubmed.ncbi.nlm.nih.gov/41675836/). *Ann Med Surg (Lond)*. [Case Report / Case Series]
Yokawa K (2026). [PMID: 41778205](https://pubmed.ncbi.nlm.nih.gov/41778205/). *Eur Heart J Case Rep*. [Case Report / Case Series]
Strachan S (2026). [PMID: 42027514](https://pubmed.ncbi.nlm.nih.gov/42027514/). *Ann Thorac Surg Short Rep*. [Case Report / Case Series]
Wang W (2026). [PMID: 42159451](https://pubmed.ncbi.nlm.nih.gov/42159451/). *J Hypertens*. [Review / Meta-Analysis]
Lou X (2026). [PMID: 41408087](https://pubmed.ncbi.nlm.nih.gov/41408087/). *Eur J Cardiothorac Surg*. [Epidemiology / Natural History]
Wanhainen A (2026). [PMID: 41448425](https://pubmed.ncbi.nlm.nih.gov/41448425/). *Eur J Vasc Endovasc Surg*. [Review / Meta-Analysis]
Demirbaş ZE (2026). [PMID: 41642011](https://pubmed.ncbi.nlm.nih.gov/41642011/). *Turk Gogus Kalp Damar Cerrahisi Derg*. [Case Report / Case Series]
Tanasidis C (2026). [PMID: 41571014](https://pubmed.ncbi.nlm.nih.gov/41571014/). *Zentralbl Chir*. [Clinical Trial Publication]
Akdoğan M (2026). [PMID: 41755491](https://pubmed.ncbi.nlm.nih.gov/41755491/). *Cardiol Young*. [Case Report / Case Series]
Schoeman S (2026). [PMID: 41610941](https://pubmed.ncbi.nlm.nih.gov/41610941/). *J Vasc Interv Radiol*. [Case Report / Case Series]